E-cigarette cooling agents WS-3 and WS-23 dose-dependently enhanced autonomic imbalance and potentiated ventricular arrhythmogenesis in mice.
Cooling agents in electronic cigarettes, particularly synthetic coolants WS-3 and WS-23, enhance arrhythmogenicity and autonomic imbalance in preclinical models.
BACKGROUND: Despite the growing popularity of electronic cigarettes, evidence is mounting that vaping induces autonomic nervous system imbalance, cardiac arrhythmia, and potentially even cardiac arrest. The ingredients menthol, Wilkinson Sword (WS)-3, and WS-23 are cooling agents that enhance the appeal of electronic cigarettes (e-cigs) but bear unknown risks when inhaled. METHODS: We systematically evaluated how these coolants influence the impacts of e-cigs on cardiac and cellular electrophysiology in mice and human induced pluripotent stem cell-derived cardiomyocytes, respectively. Mice were exposed by inhalation to e-cig aerosols generated from standard e-liquid solvents and 2.5% nicotine benzoate (vehicle), or from vehicle plus menthol, WS-3, or WS-23, at increasing concentrations throughout exposure. Telemetry-derived electrocardiograms were analyzed for changes in heart rate, heart rate variability, morphology, and ventricular premature beat arrhythmias. Human induced pluripotent stem cell-derived cardiomyocytes were evaluated for the effects of serially increasing coolant concentrations on beat rate, electric field potential duration, and rate-corrected field potential duration from a newly validated formula, in the absence and presence of norepinephrine to simulate basal physiology and nicotine-evoked sympathoexcitation. RESULTS: Upon e-cig aerosol inhalation, all coolants acutely enhanced vehicle-induced autonomic imbalance, but only the synthetic coolants, WS-3 and WS-23, potentiated ventricular arrhythmogenesis. Ventricular premature beats during e-cig exposures correlated with sympathetic dominance and transient delays in ventricular repolarization measured by heart rate variability and QT interval corrected by RR interval, respectively; however, correlations were strongest for WS-23 despite no significant impact of coolants on nicotine intake. Conversely, in human induced pluripotent stem cell-derived cardiomyocytes, coolants did not affect basal physiology but slowed beat rate and shortened rate-corrected field potential duration during norepinephrine stimulation. CONCLUSIONS: Together, these data indicate that coolants dose-dependently enhance the arrhythmogenicity of e-cigs, likely through acute alterations in autonomic modulation and repolarization. Pending confirmation by human studies, these common nonnicotine additives may exacerbate e-cig cardiotoxicity and pose unique cardiovascular risks, particularly in those with arrhythmogenic susceptibility to sympathetic stimulation or slowed ventricular repolarization.
Kucera et al. (Mon,) conducted a other in E-cigarette cardiotoxicity and arrhythmogenesis. E-cigarette aerosols with cooling agents (menthol, WS-3, WS-23) vs. vehicle (standard e-liquid solvents and 2.5% nicotine benzoate) was evaluated on cardiac and cellular electrophysiology (heart rate, heart rate variability, morphology, ventricular premature beat arrhythmias). E-cigarette cooling agents WS-3 and WS-23 dose-dependently enhanced autonomic imbalance and potentiated ventricular arrhythmogenesis in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: